###begin article-title 0
CD1c bypasses lysosomes to present a lipopeptide antigen with 12 amino acids
###end article-title 0
###begin p 1
I. Van Rhijn's present address is Division of Infectious Diseases and Immunity, Faculty of Veterinary Medicine, Utrecht University, 3584CL Utrecht, Netherlands.
###end p 1
###begin p 2
###xml 542 543 542 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 588 593 <span type="species:ncbi:9606">human</span>
The recent discovery of dideoxymycobactin (DDM) as a ligand for CD1a demonstrates how a nonribosomal lipopeptide antigen is presented to T cells. DDM contains an unusual acylation motif and a peptide sequence present only in mycobacteria, but its discovery raises the possibility that ribosomally produced viral or mammalian proteins that commonly undergo lipidation might also function as antigens. To test this, we measured T cell responses to synthetic acylpeptides that mimic lipoproteins produced by cells and viruses. CD1c presented an N-acyl glycine dodecamer peptide (lipo-12) to human T cells, and the response was specific for the acyl linkage as well as the peptide length and sequence. Thus, CD1c represents the second member of the CD1 family to present lipopeptides. lipo-12 was efficiently recognized when presented by intact cells, and unlike DDM, it was inactivated by proteases and augmented by protease inhibitors. Although lysosomes often promote antigen presentation by CD1, rerouting CD1c to lysosomes by mutating CD1 tail sequences caused reduction in lipo-12 presentation. Thus, although certain antigens require antigen processing in lysosomes, others are destroyed there, providing a hypothesis for the evolutionary conservation of large CD1 families containing isoforms that survey early endosomal pathways.
###end p 2
###begin p 3
###xml 372 373 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 374 375 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 393 394 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 396 397 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 416 417 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">7</xref>
###xml 433 434 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 462 463 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
###xml 464 466 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 487 489 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 512 514 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 750 752 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 753 755 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 962 964 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">19</xref>
CD1 proteins are expressed together with beta2-microglobulin on the surface of B cells, myeloid DCs, Langerhans cells, and other APCs, where they capture and display lipid antigens to T cells. The types of lipid antigens presented by the CD1 system represent many classes of lipids that are biosynthetic products of mammalian cells or bacteria, including diacylglycerols (1-4), sphingolipids (5, 6), polyisoprenols (7), polyketides (8), mycolic acid dervatives (9-11), sulfoglycolipids (12), and other antigens (13). Most of these antigens are glycolipids that insert their aliphatic hydrocarbon chains into the hydrophobic groove of CD1 so that the carbohydrate moieties protrude from the groove, making them available for direct contact with TCRs (14-18). A recent ternary crystal structure of an alphabeta TCR bound to a CD1d-alpha-galactosyl ceramide complex shows how the variable regions of the TCR contact a galactose moiety lying on the surface of CD1d (19). Although T cells had previously been thought to recognize mainly linear primary amino acid sequences, these studies show how T cells with rearranged alphabeta TCRs can also discriminate the structure of carbohydrate rings.
###end p 3
###begin p 4
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 1227 1229 1220 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">23</xref>
###xml 442 447 <span type="species:ncbi:9606">human</span>
However, the larger family of CD1 antigen-presenting molecules (CD1a, CD1b, CD1c, and CD1d) presents not only antigens with head groups that are sugars, but also antigens that are composed of free fatty acids (10), polyaromatic hydrocarbons (13), hydrophobic peptides (20), and a lipopeptide. The only known lipopeptide antigen is a mycobacterial product that binds to CD1a and is named dideoxymycobactin (DDM) (21). The crystal structure of human CD1a bound to a DDM analogue shows that its single acyl group is inserted into the groove of CD1a. Its peptide chain, composed of four amino acids and two organic acids, protrudes from the groove such that the termini of the peptide are available to contact TCRs (22). These studies provide proof of principle that a CD1 protein, like MHC proteins, can present a peptide sequence to T cells. However, it is currently unclear whether the range of CD1-presented peptide antigens is limited only to this unusual and invariant mycobacterial sequence. We hypothesized that lipopeptide recognition by alphabeta T cells might involve any of the multitude of structurally varied self- or viral proteins that are encoded in DNA, assembled by ribosomes, and posttranslationally lipidated (23).
###end p 4
###begin p 5
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
In considering the possible diversity of CD1-presented lipopeptides, there are relevant evolutionary and biochemical differences between ribosomal and nonribosomal peptide synthesis pathways. DDM is made by the sequential action of enzymes known as mycobactin synthases (24). The resulting peptide is invariant in sequence. However, the chemical linkages are diverse and include esters, oxazaline rings, and amide bonds. In contrast, ribosomal translation of peptides produces a nearly infinite diversity of peptide sequences by linking each of the 20 standard amino acids by repeated amide (peptidic) bonds. Such peptide sequences are then modified in a limited number of ways on glycine, lysine, or cysteine side chains by enzymatically mediated processes known as thioacylation, lysine acylation, or myristoylation.
###end p 5
###begin p 6
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">15</xref>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">15</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 1080 1082 1080 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 1084 1086 1084 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 329 335 <span type="species:ncbi:9606">humans</span>
###xml 1303 1306 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
According to the crystal structure, the A' pocket of CD1a accepts the fatty acyl group, and the F' pocket can bind either a second fatty acyl chain or accept the peptidic moiety of DDM (15, 22). Because of the low levels of polymorphism in CD1 heavy chains, the F' pocket is thought to be invariant in structure among individual humans, so it might be specialized to bind only this 5-mer peptide of DDM. Alternatively, the F' pocket of CD1a or other CD1 isoforms instead might bind to structurally diverse molecules, as suggested by the ability of CD1a to present sulfolipids using a mechanism whereby an alkane chain resides in the F' pocket (15, 25). Ribosomally encoded peptides are highly diverse and, therefore, potentially represent a more general immune recognition pathway that could involve any peptide that contains a myristoylation, thioacylation, or prenylation site. Toll-like receptor 2-1 heterodimers recognize N-terminal cysteine-based triacylation motifs on peptides, but there is currently no evidence that acylated proteins are the targets of T cell responses (26, 27). As a first step toward testing this general hypothesis, we prepared several synthetic lipopeptides that mimic acylated sequences contained within larger proteins produced by mammalian cells (IL-1alpha) or viruses (HIV and EBV), and carry an acyl group on the N-terminal glycine or cysteine or internal lysine residues.
###end p 6
###begin p 7
Although antigen screens initially focused on CD1a because it is the only protein known to present a lipopeptide, we unexpectedly found that cellular CD1c proteins presented an N-terminal acylated glycine dodecamer peptide to T cells, which we designate lipo-12. This antigen mimics structures of proteins made through cellular myristoylation of proteins. We found that intact APCs deactivated antigen recognition in a process that involved peptidases. This discovery raised questions about how endosomal peptidases, which are known to control MHC-restricted peptide recognition, might also control CD1 and lipopeptide antigen complex recognition. Functional studies provided evidence for two means by which antigens can be protected from degradation in late endosomes or lysosomes. First, DDM provides an example of evolution of atypical, peptidase-insensitive linkages that allow it to persist in infected endosomes. Second, the escape of CD1a and CD1c from early endosomes to the surface allows peptidase-sensitive antigens to avoid exposure to the activated proteases in lysosomes. Most models of endosomal lipid antigen processing emphasize the sequential passage of CD1 through early and late endosomal compartments en route to the cell surface. In contrast, these results point to a model whereby the ability of CD1c to exit the endosomal pathway, before traversing lysosomes, improves antigen recognition. Although recent studies of CD1b and CD1d emphasize the importance of lysosomal factors in promoting lipid presentation, these results may explain why most mammalian species have evolved large families of CD1, including those that do not efficiently enter lysosomes.
###end p 7
###begin title 8
RESULTS
###end title 8
###begin title 9
CD1c presents a lipopeptide to T cells
###end title 9
###begin p 10
###xml 870 871 870 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 639 644 <span type="species:ncbi:9606">human</span>
###xml 684 689 <span type="species:ncbi:9606">human</span>
###xml 703 711 <span type="species:ncbi:9606">patients</span>
###xml 943 948 <span type="species:ncbi:9606">human</span>
To determine whether T cells can respond to acylated peptide sequences, we synthesized pools of peptides that were modified on N-terminal glycine, internal cysteine, or internal lysine moieties to mimic structures produced by myristoylation, thioacylatoin, or lysine acylation pathways (). These candidate antigens were synthesized using standard solid-phase peptide synthesis techniques, followed by acylation with saturated (C16:0 and C18:0) or unsaturated (C18:1) fatty acids. After purification by HPLC, mass spectrometry (MS) analysis demonstrated that products were of the expected mass (Fig. S1 and not depicted). After stimulating human T cells with acylpeptides, we screened human T cells from patients with or without viral infection for responses to acylpeptide-pulsed, monocyte-derived DCs. One of the resulting T cell lines (1A3) was found to respond to an N-acylated lipopeptide mixture when presented by DCs expressing all five human CD1 proteins (unpublished data).
###end p 10
###begin p 11
###xml 320 328 320 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 568 576 568 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 407 412 <span type="species:ncbi:9606">human</span>
Because CD1a is the only CD1 isoform previously known to bind or present a lipopeptide, testing for the cell-surface molecule that mediates the response focused on the use of anti-CD1a blocking antibodies. Unexpectedly, we found that activation was blocked by anti-CD1c antibodies but not by anti-CD1a, -CD1b, or -CD1d (Fig. 1 A). Further studies using lymphoblastoid cells transfected with any of the four human CD1 antigen-presenting proteins confirmed that T cell activation was dependent on lipopeptide dose and absolutely dependent on expression of CD1c on APCs (Fig. 1 B). Last, we found that 1A3 T cells did not cross react with other lipopeptides bearing distinct sequences and lysine acylation and thioacylation modifications, demonstrating specificity of the T cell response for the pool of N-terminal glycine acylation products (Fig. S1).
###end p 11
###begin p 12
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD1c presents lipopeptide antigens to T cells.</bold>
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1101 1102 1093 1094 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 1126 1127 1118 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 1148 1149 1140 1141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 460 465 <span type="species:ncbi:9606">human</span>
CD1c presents lipopeptide antigens to T cells. (A) [3H]Thymidine incorporation by the IL-2-sensitive HT-2 cell line was used to measure the response of polyclonal 1A3 T cells stimulated with DC and antigen. mAbs against CD1a, CD1b, CD1c, CD1d, or isotype-matched control were added at 20 microg/ml before adding antigen mixture at 0.5 microg/ml. This experiment was performed twice. (B) CD1-deficient C1R B lymphoblastoid cells transfected with cDNAs encoding human CD1a, CD1b, CD1c, CD1d, or no insert (mock) were treated with the antigen mixture before adding polyclonal 1A3 T cells and measuring IL-2 release. This experiment was performed twice. (C) Three major compounds were purified from a mixture of synthetic lipopeptide antigens using an effluent flow splitter on an HPLC interfaced to an ESI-MS. Total ion current is the basis for the relative abundance that is plotted on the y axis, and positive mode spectra corresponding to the time interval of each peak are shown. (D) The amount of each of the three major compounds was normalized for absorbance at 280 nm and used to stimulate 5 x 104 1A3 T cells with 3 x 104 DC, as measured by [3H]thymidine incorporation. Error bars represent SEM.
###end p 12
###begin p 13
###xml 966 968 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">28</xref>
###xml 970 972 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 123 128 <span type="species:ncbi:9606">human</span>
We next determined the TCR variable segments of the T cell clone by PCR using a set of primers that covered most known TCR human variable segments. This analysis reproducibly led to a strongly positive PCR signal for the TRBV12-3 segment, used in the beta chain, but products obtained with TRAV segment-specific primers were not observed (unpublished data). Because the PCR primer sets do not cover all possible variable segments, we performed inverse PCR on circularized cDNA primed with TCR alpha and beta constant region primers, followed by cloning and sequencing of the PCR product. This method confirmed that the TRBV12-3 segment was present and identified the TCR alpha chain as containing TRAV25. Determination of the complete sequences of the 1A3 TCR alpha and beta chains (available from GenBank/EMBL/DDBJ under accession nos.  and ) confirmed that they were distinct from the TCR alpha and beta chains of previously reported CD1c-restricted T cell lines (28, 29), and different from the Valpha24 chains that define invariant CD1d-restricted NK T cells ().
###end p 13
###begin title 14
Identification of the antigen as an N-terminally acylated 12-mer peptide
###end title 14
###begin p 15
###xml 374 382 374 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 528 531 528 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 701 702 701 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 706 709 706 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 898 906 898 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
To identify the precise structure of the lipopeptide antigen, the mixture of synthetic compounds was fractionated by preparative HPLC with a split interface to allow for simultaneous monitoring by UV absorbance and electrospray ionization MS (ESI-MS) and collection of samples for T cell assays. Three major lipopeptides were detected at 26, 27, and 29 min of elution time (Fig. 1 C) and were initially named lipopeptide 1, 2, and 3, respectively. Lipopeptides 1 and 3 were detected as doubly charged species at mass-to-charge (m/z) 867.4 and 868.5, corresponding to monoisotopic molecular weights of 1,732.8 and 1,735 u, respectively. Lipopeptide 2 was observed as a singly charged species with [M+H]+ at m/z 900.7 u. Testing of the purified compounds found that only lipopeptides 1 and 3 stimulated a T cell response, with lipopeptide 3 being approximately fivefold more potent on a molar basis (Fig. 1 D).
###end p 15
###begin p 16
###xml 170 176 170 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 241 248 241 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 264 265 264 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 304 306 304 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 310 313 310 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 409 412 409 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 474 475 474 475 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sub>
###xml 478 480 478 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 487 489 487 489 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 531 539 531 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 544 545 544 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 577 580 577 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 610 611 610 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 705 713 705 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 1058 1066 1058 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
To assign the compositions and elucidate the structures of the antigenic lipopeptides, we performed collision-induced dissociation MS using quadrupole ion trapping (QIT; Fig. 2 and ) and Fourier transform ion cyclotron resonance (FTICR) MS (Table I). In the QIT MS2 spectrum for lipopeptide 3, the [M+2H]2+ of m/z 1,735 generated product ions that constitute a series of peptide sequence-related fragments at m/z 1,316.8, 1,502.9, and 1,589.9. These ions correspond to the b9, b10, and b11 fragments of a C-terminal sequence, WSK (Fig. 2 B). MS3 analysis of the product ion at m/z 928.6 was consistent with an N-stearoyl hexapeptide with the amino acid sequence GGKWSK and a C-terminal hydroxyl terminus (Fig. 2 B, bottom). Formation of this fragment is best rationalized by the elimination of a peptide with kynurenine, an oxidized form of tryptophan, at its N terminus that had been released from an ester linkage to lysine at position six. Thus, the structure of lipopeptide 3 was assigned as C18:0-GGKWSKXSKWSK, where X is kynurenine with ester linkage (Fig. 2 A).
###end p 16
###begin p 17
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mass spectrometric analysis identifies antigens as acylated 12-mer peptides.</bold>
###xml 291 292 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sup>
###xml 352 353 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 459 460 459 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 467 468 467 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 622 629 622 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 636 640 636 640 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9&#8211;11</sub>
###xml 655 658 655 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 761 762 761 762 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sub>
###xml 770 773 770 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 809 812 809 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 911 912 911 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 973 974 973 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 989 990 989 990 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 992 993 992 993 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 999 1000 999 1000 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 1001 1002 1001 1002 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 1059 1060 1059 1060 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1150 1151 1150 1151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1212 1213 1212 1213 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 1230 1233 1230 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 1250 1251 1250 1251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1286 1289 1286 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 1410 1411 1410 1411 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1445 1450 1445 1446 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 1523 1526 1519 1522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 1772 1779 1768 1775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
Mass spectrometric analysis identifies antigens as acylated 12-mer peptides. (A) The three major components eluting in LC-MS experiments were named according to their HPLC elution times as lipopeptide 1, 2, or 3. The structures were deduced on the basis of low- and high-resolution MS and MSn experiments. X corresponds to a mass shift consistent with O-linked kynurenine, likely resulting from oxidation of tryptophan during the synthesis process. (B) QIT MS2 and MS3 data support the structure of lipopeptide 3. Assignments were also based on the accurate mass values measured by FTICR MS analyses that are presented in Table I. The b9-11 ion series at m/z 1,316.8, 1,502.9, and 1,589.9 corresponds to N-terminal fragments that provide the sequence WSK. The y9 ion at m/z 1,227.6 and its water loss peak at m/z 1,209.5 are consistent with the sequence C18:0-(GGK)[1,227.6] that is more fully defined by the MS3 spectrum shown in the inset. Internal ions that bracket the O-Kyn residue (am/zn and bmyn) are also present, as indicated by assignments on the MS2 spectrum. The presence of an ester linkage in the peptide backbone is confirmed by the MS3 spectrum obtained after isolation and decomposition of the c6 fragment ion at m/z 928.6. In the MS3 spectrum, the b-type fragments at m/z 509, 695, 782, and 910 indicate the sequence WSK and the presence of an ester-derived C-terminal -OH rather than the -NH2 that would have resulted from N-Calpha cleavage of an amide linkage. In addition, y-type fragments observed at m/z 420, 548, and 605 define the N terminus as C18:0-GGK. Spectra obtained during comparable experiments leading to the deduced structures of lipopeptides 1 and 2 are shown in , and the corresponding FTICR MS accurate mass assignments are listed in Table I. (C) Secretion of IL-2 by 1A3 T cells was measured in response to lipopeptide 3 (C18-GGKWSKXSKWSK) or synthetic analogues generated with C18 fatty acids carried on the N-terminal glycine or isoleucine residues presented by DCs. (D) ELISPOT detection of IFN-gamma capture in response to DCs treated with lipopeptide 3 or an analogue containing tryptophan in place of kynurenine (C18-GGKWSKWSKWSK). This experiment was performed three times with essentially the same results. *, >1,500 spots per well. (E) Recombinant CD1c-Ig fusion proteins were bound to a protein G-coated plate and treated with the indicated lipopeptide in molar excess before MPM antigen was added. After washing, the MPM-specific, CD1c-restricted T cell line CD8-1 was added and IFN-gamma release was measured by ELISA. One out of three independently performed experiments is shown. Error bars represent SEM.
###end p 17
###begin p 18
Exact mass of ions and product ions in lipo-12 as determined by FTICR-MS
###end p 18
###begin p 19
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/s</italic>
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 254 257 254 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 457 459 457 459 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sub>
###xml 460 462 460 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">29</sub>
###xml 467 469 467 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sub>
###xml 470 472 470 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sub>
Columns reflect the observed m/s (Obs. m/z), charge number of the ion (z), mass of the singly protonated molecular ion [M+H], abundance of the ion expressed as a percentage of the strongest ion (Abd.), calculated mass of the singly protonated ion (Calc. m/z), and assignment of the ion and the error of the observed mass relative to the calculated mass expressed as parts per million (Error). (#), redundant composition; R in CHRCO, acyl moiety as ketene (C14H29 or C16H33).
###end p 19
###begin p 20
###xml 120 121 120 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 123 124 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 130 131 130 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sub>
###xml 133 135 133 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 246 248 246 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sub>
###xml 249 251 249 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">29</sub>
###xml 256 258 256 258 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sub>
###xml 259 261 259 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sub>
###xml 280 281 280 281 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sub>
###xml 284 286 284 286 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 293 295 293 295 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 370 371 370 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 484 491 484 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
This conclusion is supported in more detail and with higher mass resolution by the FTICR MS, which includes the series b3-b6 and b8-b11 and their secondary fragments that arise via loss of the acyl moiety as the corresponding ketene (CHRCO, R = C14H29 or C16H33), as well as the y9, y10, and y11 fragments accompanied by water loss peaks from all of these and from the y6 ion. Internal fragment ions that include the modified, ester-linked tryptophan residue (W*) are also plentiful (Table I).
###end p 20
###begin p 21
###xml 440 448 440 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
An analogous interpretation of both FTICR and QIT spectra from lipopeptide 1 indicates that it is the same peptide as found in lipopeptide 3, except that the Gly1 of lipopeptide 1 is acylated with C18:1 rather than C18:0 (Fig. S3). This interpretation is in agreement with the synthesis scheme in which C18:0 and C18:1 fatty acids were included in the mixture used to generate the lipopeptides. The fivefold lower potency of lipopeptide 1 (Fig. 1 D) correlates with the presence of an unsaturation in its fattyl acyl chain, indicating that the lipidic portion of the molecule strongly influences its antigenicity. More generally, we conclude that CD1c can be considered the second member of the CD1 family that has been shown to present a lipopeptide to T cells. It is noteworthy that the position, amino acid residue, and chemical linkage of the fatty acyl substituent on this synthetic lipopeptide are chemically identical to that formed in N-terminal glycine acylation reactions (myristoylation) in mammalian cells.
###end p 21
###begin title 22
Lipid, peptide, and linkage specificity of the T cell response
###end title 22
###begin p 23
###xml 1349 1357 1349 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
After solving the complete structures of lipopeptides 1, 2, and 3, we next determined T cell specificity for analogues that differed in the lipid saturation, peptide length, and peptide sequence using additional synthetic lipopeptide analogues that were purified and analyzed by HPLC-MS (Figs. S4 and S5). Lipopeptide 2 was similar to the core structure of lipopeptide 3, except for a small difference in lipid length and that six residues of its C terminus were absent. Therefore, the failure of T cells to recognize lipopeptide 2 likely indicated that the longer peptide was required for recognition. The terminal amino acids may have contributed to recognition in some general way, such as promoting solubility, or represent an amino acid sequence-specific recognition event. To directly test this hypothesis, we generated a lipopeptide that retains the acyl unit and overall 12-mer length but differs from lipo-12 (C18-GGKWSKXSKWSK) in its C-terminal sequence (C18-GGKWSKSSIVGW; ). Also, we produced a point mutant at position 7 in which kynurenine is substituted with tryptophan (C18-GGKWSKWSKWSK) along with the nonacylated version (). T cells did not detectably respond to the multiply substituted 12-mer lipopeptide or the isoleucine-acylated analogue, demonstrating the importance of N- and C-terminal elements of sequence in the response (Fig. 2 C).
###end p 23
###begin p 24
###xml 187 195 187 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 D</xref>
Interestingly, the tryptophan point mutant was recognized in a dose-dependent manner, albeit at a lower titer when tested in sensitive single-cell cytokine capture ELISA (ELISPOT) assay (Fig. 2 D). This result provides evidence from a second, independently synthesized molecule that 12-mer lipopeptides can activate T cells. We conclude that a single point mutation strongly influences the potency of the response, but kynurenine is not absolutely required. Further, testing of the nonacylated peptide (GGKWSKWSKWSK) produced no detectable response (Fig. S5 and not depicted), further emphasizing the role of the acyl group in recognition.
###end p 24
###begin p 25
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 558 559 554 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">7</xref>
###xml 561 563 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 680 688 676 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 E</xref>
To determine whether these lipopeptides interact with CD1c, we measured their ability to compete against a known CD1c antigen, mannosyl phosphomycoketide (MPM), for presentation by recombinant CD1c proteins. Based on a construct for a CD1d-Ig fusion protein (2), we produced CD1c-Ig fusion protein, bound it to plastic, treated it with MPM, and washed before adding MPM-reactive T cells. MPM-treated CD1c proteins activated the MPM-reactive line CD8-1 to release IFN-gamma at high levels, providing evidence that the response requires MPM contact with CD1c (7, 30). Lipopeptide antigens did not activate CD8-1 (not depicted) but could completely inhibit the response to CD1c-MPM (Fig. 2 E). Specifically, lipo-12, as well as the tryptophan point mutant, can effectively diminish the presentation of MPM, albeit at different molar ratios. In contrast, the nonacylated form of the tryptophan mutant does not inhibit T cell response at any of the molar ratios tested. We conclude from these experiments that the acyl modification of the lipopeptides is necessary for binding of lipopeptides to CD1c, and that the difference in potency between lipo-12 and its tryptophan mutant is mainly caused by altered recognition by the 1A3 TCR.
###end p 25
###begin title 26
Antigenic glycine-1-acylpeptides are sensitive to protease degradation
###end title 26
###begin p 27
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">36</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">37</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">38</xref>
###xml 810 812 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 814 816 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 818 820 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">39</xref>
###xml 359 364 <span type="species:ncbi:9606">human</span>
###xml 783 788 <span type="species:ncbi:9606">human</span>
###xml 798 803 <span type="species:ncbi:10090">mouse</span>
The loading of exogenous antigens by CD1 proteins occurs within the endosomal network of APCs. This process requires that antigens are taken up by phagocytosis or receptor-mediated endocytosis, and that CD1 proteins are transported from the surface to endosomes after sorting interactions mediated by clathrin adaptor protein (AP) complexes (31-36). Although human CD1a proteins transit endosomes less extensively than other isoforms, they do reach sorting endosomes and can present lipids from intracellular infection (32, 37, 38). CD1c proteins recycle to endosomes based on the interactions of their cytoplasmic tail sequences with the AP-2 complex, but they enter lysosomes and localized with lysosome association membrane protein 1 (LAMP1) only at very low levels compared with human CD1b and mouse CD1d (34, 35, 39). These endosomally localized loading reactions serve to concentrate antigens, lower pH, and provide loading cofactors that promote presentation of lipid antigens other than those studied in this paper. However, endosomal antigen processing necessarily exposes both CD1 and antigens to endosomal proteases, so the discovery of CD1 antigens that contain peptide sequences raises questions about how endosomal proteases may generate or even destroy antigenic lipopeptides. Therefore, we undertook studies to measure the influence of defined proteases and natural proteolytic compartments on lipopeptide antigen recognition by T cells.
###end p 27
###begin p 28
###xml 221 229 221 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 317 318 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 363 371 363 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 651 659 651 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
When the CD1a-presented, 6-mer lipopeptide DDM was pretreated with either of two broad spectrum proteases, proteinase K and pronase, it retained its ability to stimulate T cells at the same level as mock-treated samples (Fig. 3 A). In contrast, pronase and proteinase K nearly abolished recognition of the N-terminal N-acyl lipopeptide antigen presented by CD1c (Fig. 3 B). The reduced T cell activation after protease treatment was likely caused by action on the 12-mer lipopeptides rather than nonspecific or toxic effects on cells, because adding fresh lipo-12 to the protease-antigen mixture after protease inactivation restored T cell responses (Fig. 3 C). Therefore, we conclude that DDM has intrinsic resistance to broad-spectrum proteases but the 12-mer lipopeptides, which contain typical peptide bonds, were inactivated.
###end p 28
###begin p 29
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Proteases influence recognition of lipopeptides.</bold>
Proteases influence recognition of lipopeptides. (A and B) lipo-12 and DDM were treated with proteinase K or pronase, or were mock treated in the same buffer without the proteases, and were used to stimulate 1A3 T cells and CD1a-restricted J.RT3/CD8-2 cells, respectively. Error bars represent SEM. (C) To test whether protease-treated lipo-12 itself or the inactivated proteases present in the digestion mixture were toxic to 1A3 T cells, high concentrations (10 microg/ml) of these mixtures were tested in the presence of a suboptimal amount of untreated lipo-12. (D) lipo-12 was added to DCs in the continuous absence or presence of 10 ng/ml of the protease inhibitor LHVS, and proliferation of 1A3 T cells was measured. This experiment was performed twice with essentially the same result.
###end p 29
###begin p 30
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">40</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">41</xref>
###xml 392 400 392 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
We next considered whether the naturally occurring proteases, which are normally expressed within endosomes of B cells or immature myeloid DCs, might also influence lipopeptide recognition. First, we treated DCs with the endoprotease inhibitor LHVS, an inhibitor of the lysosomal protease cathepsin S (40, 41). We reproducibly found two- to fourfold increases in the presentation of lipo-12 (Fig. 3 D). Although the augmentation in recognition was relatively small in magnitude, it was considered to be important because LHVS does not block all types of endoproteases and also because any nonspecific effects of protease inhibitors would be expected to reduce rather than to augment recognition. This result indicated that endosomal endoproteases can degrade this antigen and raised questions about how proteases distributed among the diverse subcompartments of the endosomal pathway might influence recognition.
###end p 30
###begin title 31
Redirection of CD1c trafficking to lysosomes reduces lipo-12 presentation
###end title 31
###begin p 32
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">42</xref>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 1022 1027 1022 1027 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">extra</sub>
###xml 1032 1036 1032 1036 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tail</sub>
Proteinase K, pronase, and the targets of inhibition by LHVS may not produce the same effects as the more complex array of endogenous proteases normally present in the endosomal network. To test the role of naturally occurring endosomal factors in lipopeptide presentation, we devised a means to reroute CD1c trafficking from its normal steady-state location in early endosomes so that it more efficiently reaches late endosomal and lysosomal compartments. AP-3 complexes localize broadly within the endosomal pathway and promote directed trafficking of cargo proteins to lysosomes (42). Previous studies had shown that the cytoplasmic tail sequence in CD1c (KKHCSYQDIL) binds to AP-2 but not AP-3 (32, 35). In contrast, the cytoplasmic tail sequence in CD1b (RRRSYQNIP) binds to both AP-2 and AP-3. Therefore, to reroute the antigen binding domain of CD1c to lysosomes, we produced a construct encoding a chimeric protein with CD1c extracellular and transmembrane domains fused to the CD1b cytoplasmic tail sequence (CD1cextra/CD1btail).
###end p 32
###begin p 33
###xml 340 345 340 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">extra</sub>
###xml 350 354 350 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tail</sub>
###xml 981 987 981 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4</xref>
###xml 1269 1271 1269 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 1273 1275 1273 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 1338 1343 1338 1343 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">extra</sub>
###xml 1348 1352 1348 1352 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tail</sub>
###xml 1474 1482 1474 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 1685 1693 1685 1693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 1728 1733 1728 1733 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">extra</sub>
###xml 1738 1742 1738 1742 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tail</sub>
###xml 1827 1835 1827 1835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
To facilitate visualization by two-color immunofluorescence, we cotransfected a plasmid encoding this chimera along with one encoding wild-type CD1b into C1R B lymphoblastoid cells. As a control, we produced a construct encoding the converse chimera with CD1b extracellular and transmembrane domains fused to the CD1c cytoplasmic tail (CD1bextra/CD1ctail) and coexpressed this with wild-type CD1c proteins. Confocal immunofluorescence studies were then performed using antibodies specific for the extracellular domains of CD1b or CD1c. For wild-type CD1c, we found that antibodies recognizing the extracellular domain stained predominantly at the rim of lymphoblastoid cells, which is a pattern consistent with the known distribution of CD1c at the cell surface and early endosomes. In contrast, antibodies against the extracellular domain of CD1b stained with a rim pattern as well as at many punctuate bodies located adjacent to the rim, which likely represented late endosomes (Fig. 4, top row). This interpretation is in agreement with previous studies performed in myeloid cells and HeLa cells showing that the cytoplasmic tail of CD1b confers efficient trafficking from the surface to endosomes and a higher endosomal-to-cell surface ratio than is seen for CD1c (31, 34). Using anti-CD1c to evaluate the staining pattern of the CD1cextra/CD1btail chimera, we found that the chimera had clear increases in the nonrim, punctate staining as compared with wild-type CD1c (Fig. 4 A, left column). In fact, the chimera strongly colocalized with coexpressed CD1b wild-type proteins, demonstrating that the chimeric CD1c protein was rerouted to compartments normally enriched with CD1b (Fig. 4 A, bottom row). Conversely, the CD1bextra/CD1ctail chimera lost the punctate staining pattern and appeared mainly at the rim of cells (Fig. 4 A, middle row).
###end p 33
###begin p 34
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Redirected trafficking of CD1c to lysosomes reduces lipopeptide antigen presentation.</bold>
###xml 508 513 504 509 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">extra</sub>
###xml 518 522 514 518 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tail</sub>
###xml 1008 1013 1000 1005 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">extra</sub>
###xml 1018 1022 1010 1014 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tail</sub>
###xml 1404 1406 1396 1398 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">80</sub>
###xml 1413 1415 1405 1407 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">54</sub>
###xml 1425 1427 1417 1419 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sub>
Redirected trafficking of CD1c to lysosomes reduces lipopeptide antigen presentation. (A) To enable side-by-side comparison of expression patterns of wild-type and chimeric proteins, C1R lympoblastoid cells were doubly transfected with cDNAs as indicated, permeabilized, and stained with an antibody against the extracellular part of CD1b (BCD1b.3; blue) or CD1c (F10/21A3.1; red) Pseudocolored confocal laser scanning microscopy images are shown. Bar, 10 microm. (B) Colocalization of CD1c wild-type or CD1cextra/CD1btail with LAMP1 was studied using directly labeled antibodies against the extracellular part of CD1c (F10/21A3.1; red) and LAMP1 (H4A3; transformed into green) antibodies. Colocalization of CD1c and LAMP1 is shown (yellow). Bar, 10 microm. Insets show a higher magnification of a single cell. (C) Stably transfected C1R cells were cloned, and individual clones were matched for equivalent surface expression of CD1c (white) as compared with an isotype control (gray). The expression of CD1cextra/CD1btail is shown with a thin line (MFI 585), and wild-type CD1c is shown with a thick line (569 MFI). The C1R transfectants were used to present lipo-12 to 1A3 T cells or MPM to CD8-1 T cells. The experiment shown is representative of five independently performed experiments. (D) C1R cells transfected with CD1b or with mutant CD1b with the cytoplasmic tail of CD1c were used to present C80 GMM, C54 GMM, or C32 GMM presented to LDN5 T cells. Supernatants were tested for the presence of IL-2 using the HT-2 bioassay. Error bars represent SEM.
###end p 34
###begin p 35
###xml 62 67 62 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">extra</sub>
###xml 72 76 72 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tail</sub>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 720 728 720 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
To better visualize the compartments and compare CD1c and CD1cextra/CD1btail steady-state localization in lysosomes, we performed higher resolution confocal studies in comparison to LAMP1. We analyzed stably expressing clones that were matched for equivalent levels of surface anti-CD1c staining in flow cytometry. As predicted by previous studies (31, 32, 34, 35), we observed a higher ratio of punctate-to-rim staining in the chimeric protein, suggesting redistribution from the surface to endosomes. More importantly, addition of the CD1b tail to the antigen binding domain of CD1c causes much stronger colocalization with LAMP1, indicating that this mutation drives the antigen binding domain of CD1c into lysosomes Fig. 4 B. Therefore, chimeric CD1c proteins represent a tool to measure lysosomal effects on lipopeptide antigen presentation.
###end p 35
###begin p 36
###xml 131 139 131 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 494 502 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
To measure antigen presentation, we used transfected C1R clones with equivalent cell-surface levels of wild-type or chimeric CD1c (Fig. 4 C, right). T cell stimulation assays showed that chimeric proteins were 5- to 10-fold less efficient in presenting lipo-12. This was not caused by a general loss of antigen-presenting capacity of the C1R clone or the mutant CD1c protein because MPM, a glycolipid that is not sensitive to proteases, was presented equally well by wild-type and mutant CD1c (Fig. 4 C, middle). We conclude that rerouting CD1c proteins to later endosomal compartments, which are normally used by CD1b, reduces efficiency of presentation of a lipopeptide antigen.
###end p 36
###begin p 37
###xml 90 95 90 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">extra</sub>
###xml 100 104 100 104 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tail</sub>
###xml 168 170 156 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">80</sub>
###xml 263 265 251 253 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">80</sub>
###xml 439 441 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">43</xref>
###xml 443 445 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">44</xref>
###xml 565 567 553 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sub>
###xml 573 575 561 563 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">54</sub>
Further controls using wild-type and chimeric CD1b proteins showed that expression of CD1bextra/CD1ctail provides approximately100-fold less efficient presentation of C80 glucose monomycolate (GMM) when compared with presentation by wild-type CD1b proteins. The C80 GMM antigen is a long-chain lipid whose loading is known to depend on low pH and, thus, to occur more efficiently in late endosomal and lysosomal compartments with pH <5.5 (43, 44). The presentation efficiency loss resulting from expressing the CD1b with the CD1c tail was smaller when tested with C32 and C54 GMM antigens, whose loading is less dependent on the low pH of lysosomes based on the less stringent requirements for loading antigens with smaller lipid tails. Collectively, these additional controls provide evidence for two conclusions. First, the presence or absence of AP-3 interactions and the resulting redirection to either early or late endosomes substantially influences the antigen-presenting function of CD1b and CD1c, confirming the idea of functional segregation of antigen presentation events into early and late endosomal compartments. Second, whether redirection increases or decreases the absolute efficiency of presentation depends on the identity of the antigen and the extent to which late endosomal and lysomal events influence its processing and loading.
###end p 37
###begin title 38
DISCUSSION
###end title 38
###begin p 39
###xml 224 225 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">45</xref>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">46</xref>
###xml 896 898 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">47</xref>
###xml 414 419 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 556 561 <span type="species:ncbi:9606">human</span>
The discovery of lipo-12 represents a new class of lipopeptide antigen presented by CD1 and provides the first evidence that CD1c presents lipopeptides to T cells. lipo-12 resembles ribosomally produced peptides modified by N-myristoyl transferase. In fact, the linkage of the N-terminal acylation and the first six amino acids are chemically identical to the naturally occurring acylated-Nef sequence produced by HIV-1 during cellular infection (45). Thus, at least two members of the CD1 family (CD1a and CD1c) bind and present lipopeptides. Because all human CD1 isoforms (CD1a, CD1b, CD1c, CD1d, and CD1e) traffic through endosomal compartments containing peptidases, and cathepsin S and cathepsin L have been shown to affect CD1d-restricted T cell activation, these findings raise questions about how endosomal peptidases might interact with CD1-presented antigens composed of peptides (46, 47).
###end p 39
###begin p 40
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">48</xref>
The observed inability of even broadly acting peptidases to cleave DDM likely results from atypical (nonpeptidic) linkages between individual amino and organic acids, including an oxazaline ring and an internal ester. DDM and structurally related mycobactins and carboxymycobactins undergo transport to the mycobacterial surface and release into the phagosomal space, where they directly interface with the host and bind iron for uptake into the mycobacterium (48). These unusual chemical linkages among amino acids were likely evolutionarily selected for their ability to remain intact within the phagosomal space while carrying out DDM's normal iron scavenging function.
###end p 40
###begin p 41
###xml 155 181 155 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">49</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">50</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">51</xref>
###xml 135 140 <span type="species:ncbi:9606">human</span>
###xml 155 181 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 351 357 <span type="species:ncbi:9606">humans</span>
Although the site of loading of DDM onto CD1a within infected cells and tissues has not been formally established, infection of intact human DCs with live Mycobacterium tuberculosis leads to activation of CD1a-restricted and DDM-specific T cells (21, 49). Further, CD1a is normally expressed on myeloid cells in lepromatous and tuberculous lesions in humans (50), and CD1a is up-regulated upon mycobacterial infection of immature DCs in vitro (51). These considerations and new data shown in this paper suggest a model whereby an intrinsically protease-resistant lipopeptide antigen is shed from the mycobacterial surface, traverses the phagosomal space, and contacts CD1a proteins. Such protease resistance derives directly from the nonribosomal nature of DDM biosynthesis and evolutionary pressure to function as an iron scavenger in a protease-rich compartment. Such considerations do not apply to ribosomally translated proteins containing repeating amide bonds formed between the C and N termini of amino acids, as in lipo-12.
###end p 41
###begin p 42
###xml 380 381 380 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib52">52</xref>
The discovery of T cell recognition of the synthetic lipopeptide lipo-12 expands the known reactivity of CD1 to include an N-terminally acylated peptide. This synthetic molecule is related in structure to naturally produced lipopeptides made through N-terminal glycine acylation (myristoylation) of proteins that are widely distributed in eukaryotic cells and viruses. N-terminal N-acyl glycine-modified proteins comprise 0.7% of mammalian proteins and 3.5% of viral proteins (). Such acyl proteins participate in intercellular signaling (Wnt and integrins), intracellular signaling (G proteins and neurotransmitter receptors), cell-cycle control (Src family members), and other processes. Also, viral genomes encode proteins that are normally acylated, including Nef proteins, which are important for viral budding (52).
###end p 42
###begin p 43
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib53">53</xref>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib55">55</xref>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib56">56</xref>
###xml 698 704 <span type="species:ncbi:9606">humans</span>
In contrast to DDM, lipo-12 is sensitive to degradation by proteases. This feature is not shared by previously known CD1-presented lipid antigens and raises the question of a possible role of endosomal peptidases in generating or destroying epitopes in larger acyl-proteins. Many studies of antigen processing by MHC class II found that protein degradation is not rapid and not complete during the early phases of uptake into macrophages or DCs, but instead occurs in a stepwise fashion as proteins transit from sorting to early and late endosomes and lysosomes (53-55). Immature myeloid DCs partially preserve peptide structure so that they are cleaved internally but not fully destroyed (56). In humans, immature myeloid DCs normally express CD1 proteins, so we speculate that this phenomenon may also influence lipopeptide generation and production of antigens for the CD1 system. Our studies of lipo-12 show that a lipopeptide is composed of conventional peptidic linkages and that the peptide sequence determines T cell activation. Further, lipo-12 recognition is abolished by proteases, enhanced by a cathepsin inhibitor, and reduced after redirecting CD1c protein trafficking to lysosomes.
###end p 43
###begin p 44
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib57">57</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib58">58</xref>
###xml 551 552 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">44</xref>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib59">59</xref>
###xml 601 602 601 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib60">60</xref>
###xml 607 609 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib62">62</xref>
###xml 662 664 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">63</xref>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib64">64</xref>
###xml 26 31 <span type="species:ncbi:9606">human</span>
Individual members of the human CD1 family (CD1a, CD1b, CD1c, and CD1d) differ with regard to the extent that they enter early, intermediate, or late compartments of the endosomal network (57, 58). Most previous studies have emphasized how factors present in late endosomes and lysosomes contribute in a positive way to antigen loading and recognition by T cells. Specifically, the late endosomal antigen presentation pathway facilitates antigen recognition through pH-mediated changes in CD1 conformation that increase antigen access to CD1 grooves (9, 44, 59), pH-activated lipid transfer proteins (3, 60-62), and pH-activated glycosidases that trim antigens (63, 64). Also, in theory, if all CD1 isoforms were to use late endosomal pathways, thereby traversing all endosomal compartments, this would enable them to encounter the widest possible range of antigens and load them under all available conditions.
###end p 44
###begin p 45
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
Contrary to this simple model, CD1a and CD1c do not efficiently enter late endosomes and lysosomes, where they might take advantage of such specialized lipid loading or processing cofactors (32, 34, 35). Instead, CD1a and CD1c predominantly encounter antigens in the secretory pathway and early endosomes and then return to the surface without localizing in lysosomes at steady state (32, 34, 35). Furthermore, inspection of the sequences of nonhuman CD1 genes suggests that most mammals have large CD1 families containing examples of two types of CD1 proteins: those that are and those that are not predicted to enter lysosomes. What, then, are the potential selective advantages that underlie the evolutionary retention of isoforms that enter early but not late endosomal pathways?
###end p 45
###begin p 46
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
One candidate mechanism that is illustrated in studies shown in this paper is that early endosomes might concentrate antigens and CD1 proteins for loading, yet expose the antigens to chemically and enzymatically mild conditions that allow antigens to remain intact during and after loading reactions. Certain antigens, such as lipopeptides and sulfatides, may be most efficiently presented if they load at the cell surface (25, 32) or if the complex escapes from the early endosomal environment to the surface before entry into the degradative environment of late endosomes and lysosomes.
###end p 46
###begin p 47
More so than the peptide ligands for MHC class II, the ligands for CD1 proteins are diverse in their structures and chemical reactivity. They can be composed of lipids, peptides, phosphate esters, sulfoesters, and carbohydrates. Known antigens range from lipopeptides, which are cleaved by ubiquitous enzymes, to free mycolic acid, which is a chemically inert compound that is catabolized by specialized, multistep enzymatic systems. As contrasted with models in which CD1 is thought to sequentially sample all endosomal compartments, these studies emphasize the distinction between functionally separate early pathways used by CD1a and CD1c, and late pathways used more extensively by CD1b and CD1d. This dual system could allow presentation of those antigens requiring chemically mild loading conditions, and other antigens needing loading factors and pH-driven changes in CD1 or antigen structure found in late endosomes. We speculate that the chemical diversity of CD1-restricted antigens provides evolutionary pressure for any given mammalian species to retain larger numbers of CD1 genes, including CD1 proteins that sample lysosomes and those that do not.
###end p 47
###begin p 48
###xml 1089 1091 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib52">52</xref>
###xml 1093 1095 1086 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib65">65</xref>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 954 957 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 966 983 <span type="species:ncbi:10407">hepatitis B virus</span>
Collectively, the discovery of lipo-12 as a CD1-presented antigen for human alphabeta T cells and the identification of the N-terminal acylation as the key unit that facilitates presentation of the antigen by CD1c raise the possibility that other N-terminally acylated peptides, including posttranslationally modified products of ribosomal translation, might also be antigens for the CD1 system. All previously known CD1-presented antigens are not encoded by a host or pathogen genome, but instead are generated by series of enzymatic steps to produce antigens of nearly invariant structure, which has led to the view that CD1-presented antigens always have conserved structures. The data we present in this paper raise the possibility that chemically more diverse and mutable antigens composed of amino acid sequences encoded in host or pathogen genomes could also be antigens for the CD1 system. Interestingly, the viral N-terminally acylated proteins HIV Nef and hepatitis B virus large surface antigen lose their function if mutated in a way that they lose their N-terminal acylation (52, 65). This provides a candidate mechanism for coupling of pathogenicity and binding capacity to the antigen-presenting element.
###end p 48
###begin title 49
MATERIALS AND METHODS
###end title 49
###begin title 50
Antigens
###end title 50
###begin p 51
###xml 70 71 70 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 649 650 649 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 808 809 808 809 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 812 813 812 813 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Lipopeptides were prepared by automated peptide synthesis followed by N-acylation of a peptidic backbone with a mixture of fatty acids (C14:0, C16:0, C18:0, C18:1, and C20:0; Anaspec Corporation). The unsaturated fatty acids were from Sigma-Aldrich, and C18:1 (trans-2-octadecenoic acid) was from Matreya. Analogues of lipo-12 were prepared by first synthesizing the peptide backbones on a solid-phase peptide synthesizer (ABI 433A; Applied Biosystems) using Wang resin (Dana-Farber Cancer Institute Core Facility). Lysine and tryptophan were Boc protected, whereas the rest of the amino acids were Fmoc protected on their side chains. Finally, the N-stearoyl modification (Sigma-Aldrich) of the peptidic backbone was performed, and the lipopeptide was released, dried under nitrogen gas, resuspended in CHCl3/CH3OH (1:1 vol/vol), and analyzed by HPLC-MS for purity and confirmation of the expected mass.
###end p 51
###begin p 52
###xml 460 461 460 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 465 466 465 466 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 470 471 470 471 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 751 752 751 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sup>
###xml 1164 1167 1160 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 1374 1389 1370 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 1416 1418 1412 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 1374 1389 <span type="species:ncbi:1773">M. tuberculosis</span>
Antigenic compounds and analogues of lipo-12 were fractionated by HPLC with a sample-splitting interface to allow for simultaneous preparative collection of samples for T cell assays and detection based on ultraviolet light absorbance (254 and 280 nm), and ESI-MS with QIT (Finnigan LCQ Advantage [Thermo Fisher Scientific] or Accurate Mass QTOF [Agilent Technologies]). A C18 (Vydac) column was used with a gradient elution based on solvent A (80:20 vol/vol H2O/CH3CN/H2O with 0.02% TFA and 0.1% HCOOH) and solvent B (50:30:20 methanol/acetonitrile/water with 0.02% TFA and 0.1% formic acid) using a flow rate of 0.7 ml/min, and a gradient starting at 50% B and running to 95% B over 20 min and holding at 95% B for the final 10 min. More detailed MSn experiments were performed by nano-ESI using borosilicate glass capillaries pulled to a final orifice of 1-2 microm and an internal stainless steel electrode. For biological testing, fractions were collected at 15-s intervals with an automatic fraction collector, evaporated to dryness under nitrogen, and tested for stimulation of T cells. To yield highly pure analogues of lipo-12, fractions with the desired m/z value were combined, and dried under nitrogen gas, resuspended in solvent A/solvent B (9:1), and again subjected to the described HPLC method to yield samples with the highest purity. DDM was purified from M. tuberculosis, as previously described (21).
###end p 52
###begin title 53
Structural characterization of lipo-12
###end title 53
###begin title 54
FTICR MS.
###end title 54
###begin p 55
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib66">66</xref>
###xml 253 255 253 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3+</sup>
###xml 263 265 263 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 279 280 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
The lipo-12 mixture obtained in the initial synthesis was subjected to nano-ESI-MS analysis using a home-built qQq FTICR MS instrument (66) fitted with a 7-Tesla actively shielded magnet (Cryomagnetics Inc.). Accurate masses were measured for the [M+3H]3+, [M+2H]2+, and/or [M+H]+ ions, and the products were obtained for selected precursors that were subjected to collision-induced decomposition. The front-end quadrupoles were controlled using the program LC2Tune 1.5 (MDS Analytical Technologies), and the program IonSpec99 (IonSpec Corp.) controlled data acquisition in the ion cyclotron resonance cell. Spectra were analyzed using the Boston University Data Analysis software, developed in house.
###end p 55
###begin p 56
###xml 84 85 84 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 89 90 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The lipopeptide sample was diluted 1:40 from its original concentration using 1:1 CH3OH/H2O (vol/vol), 1% HCOOH solution, and was sprayed using a home-built nanospray source. The solution was loaded into a Kwik-Fil borosilicate glass capillary tip (1-microm orifice diameter) pulled in house with a micropipette puller (P-97 Flaming/Brown; Sutter Instrument Co.). Kwik-Fil borosilicate glass capillaries, HPLC-grade methanol, and formic acid were obtained from VWR International. All water was filtered using a filtration system (Milli-Q Gradient A10; Millipore).
###end p 56
###begin p 57
###xml 10 12 10 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3+</sup>
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 191 192 191 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 403 406 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 439 441 439 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3+</sup>
###xml 453 454 453 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sub>
###xml 460 461 460 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
The [M+3H]3+ ions of lipopeptides 1 and 3 and the [M+H]+ ion of lipopeptide 2 were isolated in the resolving quadrupole and accelerated at 10 eV into the LINAC quadrupole for collision with N2 gas. Fragment ions were accumulated for 1000 ms and transmitted to the ICR cell for detection. All spectra were analyzed without apodization and with two zero fills, and were internally calibrated based on the m/z values calculated for the [M+3H]3+ ions, the y9 and c6 fragments, and their isotopes.
###end p 57
###begin title 58
QIT MS.
###end title 58
###begin p 59
###xml 173 175 161 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 422 425 410 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nth</sup>
Compounds of interest were analyzed by isolating the parent ions in the QIT MS, collisionally activating them with the helium buffer present at low pressure (approximately10-5 Torr), and, finally, sequentially ejecting the product ions from the trap for mass analysis. These experiments were performed both during the HPLC-MS runs with ESI for initial MS/MS analysis and also using offline nano-ESI-MS for more detailed MSnth analysis with multiple stages of fragmentation.
###end p 59
###begin title 60
Derivation of T cell lines
###end title 60
###begin p 61
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 114 115 114 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 253 254 249 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 276 277 272 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 881 882 877 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 945 946 941 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 67 70 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 72 80 <span type="species:ncbi:9606">patients</span>
###xml 573 577 <span type="species:ncbi:9913">calf</span>
To generate CD1-restricted T cells, primary human lymphocytes from HIV+ patients were handled in biosafety level 2+ conditions by stimulation with monocyte-derived immature DCs and a synthetic antigen mixture at a concentration of 1 microg/ml. 1.25 x 105 T cells and 0.25 x 105 DCs per well were cultivated in round-bottom 96-well plates. For the first three rounds of stimulation, autologous DCs were used, and heterologous DCs were used for subsequent stimulations. Lines were cultivated in T cell medium made by supplementing 500 ml RPMI 1640 medium with 50 ml of fetal calf serum (Hyclone), penicillin (Invitrogen), streptomycin (Invitrogen), 20 mM Hepes (Invitrogen), and 4 ml 1 N NaOH solution. The IL-2 concentration was initially 0.1 nM and gradually increased to 1 nM during subsequent rounds of stimulation. T cell clones were derived by limiting dilution, using 0.6 x 105 EBV-transformed and irradiated B cells (10,000 R) and 1.3 x 105 heterologous irradiated PBMCs (3,300 R) as feeder cells, and 1 microg/ml PHA (Difco) in medium containing 2 nM IL-2.
###end p 61
###begin title 62
T cell assays
###end title 62
###begin p 63
###xml 51 52 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 212 213 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 741 745 <span type="species:ncbi:9925">goat</span>
###xml 751 756 <span type="species:ncbi:10090">mouse</span>
T cell activation was measured by incubating 5 x 104 T cells with 3 x 104 DCs or CD1-transfected C1R cells. Proliferation was measured after co-culture for 3 d with antigen, followed by a 6-h pulse of 1 microCi [3H]thymidine before harvesting and counting beta emissions. Alternatively, supernatants were tested for the presence of IL-2 using the HT-2 bioassay. Anti-CD1a (OKT6), -CD1b (BCD1b.3), -CD1c (F10/21A3.1), -CD1d (CD1d42), and -IgG1 control (P3) were used for blocking studies at 20 microg/ml. For studies with C1R cells expressing wild-type or chimeric CD1 proteins, a panel of clones was tested for surface expression by flow cytometric analysis after staining with antibodies to CD1c (F10/21A3.1), or CD1b (BCD1b.3) followed by goat anti-mouse PE on nonpermeabilized cells. Clones with equivalent levels of CD1 expression as measured by mean fluorescence intensity (MFI) of nonpermeabilized cells within 1d of the assay were used to compare antigen presentation function.
###end p 63
###begin p 64
###xml 308 309 288 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 412 413 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 931 935 897 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FAST</italic>
###xml 264 270 <span type="species:ncbi:9913">bovine</span>
For enzyme-linked immunosorbent spot (ELISPOT), polyvinylidene difluoride-backed 96-well plates (Millipore) were coated with 2.5 microg/ml anti-IFN-gamma mAb 1-D1K (Mabtech) at 4degreesC for 16 h and blocked with RPMI 1640 (Invitrogen) supplemented with 10% fetal bovine serum for 1 h at 37degreesC. 2.5 x 104 monocyte DCs were added to wells with serial dilutions of lipopeptide antigens and coincubated with 104 T cells for 16 h at 37degreesC. After incubation, the plates were washed six times with PBS containing 0.05% Tween 20, and incubated with 0.3 microg/ml of biotinylated anti-IFN-gamma mAb 7-B6-1-biotin (Mabtech) for 2 h at room temperature. Plates were washed again and incubated with streptavidin-conjugated alkaline phosphatase (Sigma Aldrich) for 1 h. Individual cytokine-producing cells were identified as spots after a 10-20-min reaction with 5-bromo-4-chloro-3-indolyl phosphate and nitro blue tetrazolium (SIGMAFAST BCIP/NBT; Sigma Aldrich). An ImmunoSpot S5 Macro Analyzer (Cellular Technology Ltd.) was used for enumeration of the spots.
###end p 64
###begin title 65
Competition assays for recombinant CD1c
###end title 65
###begin p 66
###xml 184 185 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 748 749 731 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 8 13 <span type="species:ncbi:9606">human</span>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
Soluble human CD1c fusion proteins covalently linked to human beta2-microglobulin and to the Fc portion of mouse IgG2a were constructed, produced, and purified as previously reported (2). 96-well protein G-coated plates (Thermo Fisher Scientific) were incubated with 1.25 microg of CD1c fusion protein and 125 ng anti-CD11a (AbD Serotec) per well in PBS, pH 7.4, overnight at room temperature. After the plates were washed three times with PBS buffer, lipoprotein competitors were sonicated into PBS and added to the wells in molar excess. The plates were incubated for 8 h at 37degreesC before adding MPM for additional 18-h incubation at room temperature. The plate was then washed three times with 200 microl/well of sterile PBS before adding 105 CD8-1 T cells in a total volume of 200 microl of T cell medium per well. The plates were incubated for 24 h at 37degreesC, after which culture supernatants were collected for IFN-gamma ELISA analysis (Thermo Fisher Scientific). Control experiments demonstrated that CD8-1 was restricted by CD1c, reactive to MPM, and not directly reactive to lipopeptides (unpublished data).
###end p 66
###begin title 67
Generation of C1R (double) transfectant cell lines and confocal microscopy
###end title 67
###begin p 68
###xml 225 230 225 230 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">extra</sub>
###xml 235 239 235 239 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tail</sub>
###xml 446 451 446 451 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">extra</sub>
###xml 456 460 456 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tail</sub>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 252 257 <span type="species:ncbi:9606">human</span>
To create tail swap mutants, human CD1c cDNA was amplified with the 5' primer VB06 (5'-ATCAGCAAACAGCTTTTCTGAGAG-3') and the 3' primer VB05 (5'-TCATGGGATATTCTGATATGACCGGCGCCTCATAAACCATAACACAAGGACTATTAG-3') to generate the CD1cextra/CD1btail mutant, and human CD1b cDNA was amplified with the 5' primer VB07 (5'-ACCAGCTCTGCCAGTAAGAAGTTGC-3') and the 3' primer VB04 (5'-TCACAGGATGTCCTGATATGAGCAGTGCTTCTTATACCATAATGCAAGGCATAG-3') to generate the CD1bextra/CD1ctail mutant. PCR reactions were performed using High Fidelity Platinum Taq DNA polymerase (Invitrogen), and the PCR fragments were cloned into the pEF6-TOPO TA vector (Invitrogen). The cloned inserts were confirmed by DNA sequencing. Transfection of C1R cells expressing either wild-type CD1b or CD1c was performed via electroporation, as previously described (31), and cells expressing the new chimeric or point mutant CD1 molecules were selected in tissue culture medium containing 10 microg/ml blasticidin.
###end p 68
###begin p 69
###xml 62 63 62 63 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 316 321 <span type="species:ncbi:10090">mouse</span>
###xml 466 471 <span type="species:ncbi:10090">mouse</span>
###xml 512 517 <span type="species:ncbi:10090">mouse</span>
The transfected C1R cells were attached to cover slides (poly-l-lysine coated), fixed with 4% paraformaldehyde, and permeabilized with 0.05% saponin, as previously described (34). For double staining of CD1b and CD1c, the extracellular domain of CD1b was detected with 5 microg/ml of the mAb 4A7 and revealed with a mouse IgG2a-specific, Alexa Fluor 647-conjugated antibody (Invitrogen). The CD1c extracellular domain was detected with 5 microg/ml of the monoclonal mouse antibody F10/21A3.1 and revealed by the mouse IgG1-specific, Alexa Fluor 555-conjugated antibody (Invitrogen). The slides were analyzed with a laser scanning confocal microscope (Radiance 2000; Bio-Rad Laboratories), and representative images are shown in the figures. For CD1c and LAMP1 double staining, the F10/21A3.1 antibody and the anti-LAMP1 H4A3 antibody (BD) were directly conjugated to Alexa Fluor 546 and Alexa Fluor 647, respectively (using a labeling kit; Invitrogen), as well as the IgG1 isotype control antibody P3. Slides were analyzed on a confocal laser scanner (TE2000-U C1; Nikon).
###end p 69
###begin title 70
In vitro protease treatment
###end title 70
###begin p 71
Pronase is a mixture of endopeptidases and exopeptidases (carboxypeptidases and aminopeptidases) that cleave denatured and native proteins down into individual amino acids. Proteinase K is an endopeptidase that has a preference for cleavage between an aliphatic, aromatic, or hydrophobic and any other amino acid; however, it will digest any peptidic bond if added in excess and/or allowed to interact over long incubation periods. Pronase and proteinase K were used to digest lipo-12 and DDM in protease buffer (10 mM CaCl, 10 mM Hepes buffer, 25 mM ammonium bicarbonate) for 4 h at 40degreesC, followed by 10 min of inactivation at 85degreesC. Mock treatment of antigens was performed in the same buffer and at the same temperatures, but without addition of the proteases.
###end p 71
###begin title 72
TCR cloning
###end title 72
###begin p 73
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 388 404 374 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 430 437 416 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 505 512 491 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 388 404 <span type="species:ncbi:562">Escherichia coli</span>
###xml 430 437 <span type="species:ncbi:562">E. coli</span>
###xml 505 512 <span type="species:ncbi:562">E. coli</span>
mRNA was isolated from 106 clonal or polyclonal T cells using an Oligotex Direct mRNA kit (QIAGEN), followed by first-strand cDNA synthesis using SuperScript RT (Invitrogen). PCR primer sets as described on the Immunogenetics website () covering most of the TCR Valpha and Vbeta families were used to determine the Valpha and Vbeta usage. Second-strand cDNA synthesis was performed using Escherichia coli DNA ligase (Invitrogen), E. coli DNA pol I (Invitrogen), and RNase H (New England Biolabs, Inc.) in E. coli ligase buffer (Invitrogen), followed by blunting of the material with T4 polymerase and circularization using T4 ligase. Inverse PCR using the constant regions of the TCR alpha and TCR beta (Calpha and Cbeta) was performed using the following primers: CircularCalphaForward, 5'-GACCTCATGTCTAGCACAGTTTTG-3'; CircularCalphaReverse, 5'-GCCCTGCTATGCTGTGTGTCT-3'; CircularCbetaForward, 5'-ACACAGCGACCTCGGGAGGG-3'; and CircularCbetaReverse, 5'-GATGGCCATGGTCAAGAGAAAGGA-3'. Primers for full-length TCR chains were: FLTRBV12-3, 5'-GCCATGGACTCCTGGACCTTCTGCT-3'; and FLTRAV25, 5'-GGGAGATGCTACTCATCACATCAATGTTG-3'. PCR products were cut from an agarose gel, purified, and ligated in a Topo4blunt vector that was used to transform one-shot Top10 cells (Invitrogen). Vector DNA of single colonies was sequenced by Baseclear.
###end p 73
###begin title 74
Online supplemental material
###end title 74
###begin p 75
###xml 192 193 192 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Fig. S1 shows T cell recognition of synthetic lipopeptides mimicking acylated proteins from mammalian cells or viruses. Fig. S2 depicts the amino acid sequence of the 1A3 TCR. Fig. S3 shows MS2 data supporting the structure of lipopeptides 1 and 2. Fig. S4 depicts the synthesis and analysis of 12-mer lipopeptides. Fig. S5 shows the synthesis and analysis of tryptophan point mutant at position 7. Online supplemental material is available at .
###end p 75
###begin title 76
Supplementary Material
###end title 76
###begin title 77
[Supplemental Material Index]
###end title 77
###begin p 78
We thank W. Peng for providing the construct for the CD1c-Ig fusion protein.
###end p 78
###begin p 79
This work was supported by the National Institute of Allergy and Infectious Diseases (grant R01 AI049313 to D.B. Moody and grant AI45889 to S.A. Porcelli), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant R01 AR048632 to D.B. Moody), the American Lung Association (grant RT-95-N to I. Van Rhijn), the National Institutes of Health/National Center for Research Resources (grant P41 RR10888 to C.E. Costello), the Pew Foundation Scholars in the Biomedical Sciences, and the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research.
###end p 79
###begin p 80
The authors have no conflicting financial interests.
###end p 80
###begin article-title 81
CD1-restricted T cell recognition of microbial lipoglycan antigens.
###end article-title 81
###begin article-title 82
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine CD1d-restricted T cell recognition of cellular lipids.
###end article-title 82
###begin article-title 83
Assistance of microbial glycolipid antigen processing by CD1e.
###end article-title 83
###begin article-title 84
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria.
###end article-title 84
###begin article-title 85
Recognition of bacterial glycosphingolipids by natural killer T cells.
###end article-title 85
###begin article-title 86
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.
###end article-title 86
###begin article-title 87
###xml 62 88 62 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 62 88 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection.
###end article-title 87
###begin article-title 88
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells.
###end article-title 88
###begin article-title 89
###xml 31 36 <span type="species:ncbi:9606">human</span>
CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen.
###end article-title 89
###begin article-title 90
Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells.
###end article-title 90
###begin article-title 91
Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells.
###end article-title 91
###begin article-title 92
###xml 118 144 118 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 118 144 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis.
###end article-title 92
###begin article-title 93
CD1d-restricted T cell activation by nonlipidic small molecules.
###end article-title 93
###begin article-title 94
###xml 13 18 <span type="species:ncbi:9606">human</span>
Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chains.
###end article-title 94
###begin article-title 95
Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A.
###end article-title 95
###begin article-title 96
###xml 25 30 <span type="species:ncbi:9606">human</span>
The crystal structure of human CD1b with a bound bacterial glycolipid.
###end article-title 96
###begin article-title 97
Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity.
###end article-title 97
###begin article-title 98
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: a molecular basis for NKT cell activation.
###end article-title 98
###begin article-title 99
CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
###end article-title 99
###begin article-title 100
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Peptide binding and presentation by mouse CD1.
###end article-title 100
###begin article-title 101
T cell activation by lipopeptide antigens.
###end article-title 101
###begin article-title 102
Molecular mechanism of lipopeptide presentation by CD1a.
###end article-title 102
###begin article-title 103
T-cell activation by lipopeptide antigens.
###end article-title 103
###begin article-title 104
###xml 20 46 20 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 20 46 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Identification of a Mycobacterium tuberculosis gene cluster encoding the biosynthetic enzymes for assembly of the virulence-conferring siderophore mycobactin.
###end article-title 104
###begin article-title 105
Presentation of the same glycolipid by different CD1 molecules.
###end article-title 105
###begin article-title 106
Recognition of lipopeptides by Toll-like receptors.
###end article-title 106
###begin article-title 107
The surprising diversity of lipid antigens for CD1-restricted T cells.
###end article-title 107
###begin article-title 108
Molecular recognition of lipid antigens by T cell receptors.
###end article-title 108
###begin article-title 109
CD1a-, b-, and c-restricted TCRs recognize both self and foreign antigens.
###end article-title 109
###begin article-title 110
CD1c presentation of synthetic glycolipid antigens with foreign alkyl branching motifs.
###end article-title 110
###begin article-title 111
The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens.
###end article-title 111
###begin article-title 112
Separate pathways for antigen presentation by CD1 molecules.
###end article-title 112
###begin article-title 113
A critical tyrosine residue in the cytoplasmic tail is important for CD1d internalization but not for its basolateral sorting in MDCK cells.
###end article-title 113
###begin article-title 114
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens.
###end article-title 114
###begin article-title 115
Intracellular trafficking pathway of newly synthesized CD1b molecules.
###end article-title 115
###begin article-title 116
Intracellular pathways of CD1 antigen presentation.
###end article-title 116
###begin article-title 117
Intersection of group I CD1 molecules and mycobacteria in different intracellular compartments of dendritic cells.
###end article-title 117
###begin article-title 118
CD1a and MHC class I follow a similar endocytic recycling pathway.
###end article-title 118
###begin article-title 119
CD1c molecules broadly survey the endocytic system.
###end article-title 119
###begin article-title 120
Vinyl sulfones as mechanism-based cysteine protease inhibitors.
###end article-title 120
###begin article-title 121
Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading.
###end article-title 121
###begin article-title 122
Signals for sorting of transmembrane proteins to endosomes and lysosomes.
###end article-title 122
###begin article-title 123
Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation.
###end article-title 123
###begin article-title 124
Role of lipid trimming and CD1 groove size in cellular antigen presentation.
###end article-title 124
###begin article-title 125
###xml 68 76 <span type="species:ncbi:9606">patients</span>
A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients.
###end article-title 125
###begin article-title 126
Thymocyte expression of cathepsin L is essential for NKT cell development.
###end article-title 126
###begin article-title 127
Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S.
###end article-title 127
###begin article-title 128
###xml 50 76 50 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 50 76 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages.
###end article-title 128
###begin article-title 129
Differential effects of cytolytic T cell subsets on intracellular infection.
###end article-title 129
###begin article-title 130
###xml 37 42 <span type="species:ncbi:9606">human</span>
CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity.
###end article-title 130
###begin article-title 131
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Mycobacterium tuberculosis regulates CD1 antigen presentation pathways through TLR-2.
###end article-title 131
###begin article-title 132
###xml 24 59 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: analysis of its role in enhancement of viral infectivity.
###end article-title 132
###begin article-title 133
Lysosomal cysteine proteases regulate antigen presentation.
###end article-title 133
###begin article-title 134
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner.
###end article-title 134
###begin article-title 135
The lysosomal cysteine proteases in MHC class II antigen presentation.
###end article-title 135
###begin article-title 136
Activation of lysosomal function during dendritic cell maturation.
###end article-title 136
###begin article-title 137
Conservation of CD1 intracellular trafficking patterns between mammalian species.
###end article-title 137
###begin article-title 138
Diversification of CD1 proteins: sampling the lipid content of different cellular compartments.
###end article-title 138
###begin article-title 139
pH-dependent interdomain tethers of CD1b regulate its antigen capture.
###end article-title 139
###begin article-title 140
Apolipoprotein-mediated pathways of lipid antigen presentation.
###end article-title 140
###begin article-title 141
Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins.
###end article-title 141
###begin article-title 142
###xml 48 53 <span type="species:ncbi:9606">human</span>
Saposin C is required for lipid presentation by human CD1b.
###end article-title 142
###begin article-title 143
Glycolipid antigen processing for presentation by CD1d molecules.
###end article-title 143
###begin article-title 144
Lysosomal glycosphingolipid recognition by NKT cells.
###end article-title 144
###begin article-title 145
###xml 21 38 <span type="species:ncbi:10407">hepatitis B virus</span>
Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity.
###end article-title 145
###begin article-title 146
Characterization of a new qQq-FTICR mass spectrometer for post-translational modification analysis and top-down tandem mass spectrometry of whole proteins.
###end article-title 146
###begin p 147
###xml 220 223 220 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
Abbreviations used: AP, adaptor protein; DDM, dideoxymycobactin; ESI, electrospray ionization; FTICR, Fourier transform ion cyclotron resonance; GMM, glucose monomycolate; LAMP1, lysosome association membrane protein 1; m/z, mass-to-charge; MFI, mean fluorescence intensity; MPM, mannosyl phosphomycoketide; MS, mass spectrometry; QIT, quadrupole ion trapping.
###end p 147

